Lori Macomber

Lori Macomber is a declared insider of Karyopharm Therapeutics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 31 January 2025 to 3 February 2026, the count stands at 4 filings.

Sales make up the whole of the open-market record (1 sale, €8,682). Besides market trades, the filings include 3 share grants. 2026 to date brings no purchases and 1 sale.

On 4 February 2026 came the latest disclosure, an open-market sale for €8,682 in Karyopharm Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.